low-dose lymphocyte immunotherapy
BL2015007
Phase 2 other completed
Quick answer
low-dose lymphocyte immunotherapy for Unexplained Recurrent Miscarriage and Recurrent Implantation Failure is a Phase 2 program (other) at Nanjing Zenshine Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nanjing Zenshine Pharmaceuticals
- Indication
- Unexplained Recurrent Miscarriage and Recurrent Implantation Failure
- Phase
- Phase 2
- Modality
- other
- Status
- completed